Publikationen von K. T. Pan
Alle Typen
Konferenzbeitrag (7)
21.
Konferenzbeitrag
132 (Suppl. 1), 3846, (2018)
The vascular bone marrow niche influences outcome in chronic myeloid leukemia. 60th Annual Meeting of the American Society of Hematology (ASH), San Diego, Calif., 01. Dezember 2018 - 04. Dezember 2018. Blood 22.
Konferenzbeitrag
39 (Suppl.), S. 219 - 219 (2016)
Elucidation of tonic and activated B cell receptor signaling in Burkitt's lymphoma reveals insights into non-oncogene addiction. Oncology Research and Treatment 23.
Konferenzbeitrag
101 (Suppl. 1), S. 166 - 166 (2016)
A novel epigenetic resistance mechanism to the FLT3 inhibitor PK412 induces cross-resistance to standard chemotherapy in acute myeloid leukemia (AML). 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, 09. Juni 2016 - 12. Juni 2016. Haematologica 24.
Konferenzbeitrag
101 (Suppl. 1), S. 45 - 45 (2016)
Identification of novel B cell receptor antigens in chronic lymphocytic leukemia. 21st Congress of the European-Hematology-Association, Copenhagen, Denmark, 09. Juni 2016 - 12. Juni 2016. Haematologica 25.
Konferenzbeitrag
126 (23), (2015)
Identification of B cell receptor antigens in the chronic lymphocytic leukemia microenvironment. 57th Annual Meeting of the American-Society-of-Hematology, Orlando, FL, 05. Dezember 2015 - 08. Dezember 2015. Blood 26.
Konferenzbeitrag
10 (Suppl. 2), 9 Aufl., S. S293 - 293 (2015)
Proteomic profiling of pulmonary cancer with squamous cell histology. Journal of Thoracic Oncology 27.
Konferenzbeitrag
100 (Suppl. 1), S. 178 - 178 (2015)
The B cell reseptor signaling output in Burkitt´s lymphoma is genotype specific and impacts sensitivity towards BCR signaling inhibitors. 20th Congress of the European Hematology Association , Vienna, Austria, 11. Juni 2015 - 14. Juni 2015. Haematologica